Echocardiographic Assessment of Cardiac Amyloidosis

Поділитися
Вставка
  • Опубліковано 18 жов 2024
  • Speaker: Chi-Ming Chow MD MSc FRCPC FASE FCCS
    Director of Echo Lab, St. Michael's Hospital
    Professor in Medicine, University of Toronto
    Date: June 9, 2022
    Objectives:
    1) Describe what is amyloid and the cardiac involvement
    2) Describe the classic echo features of cardiac amyloid
    3) Describe the novel and emerging echo features of cardiac amyloid
    4) Describe the artificial intelligence in the assessing cardiac amyloid
    Reference:
    Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis
    Can J Cardiol. 2020 Mar;36(3):322-334. doi: 10.1016/j.cjca.2019.12.034.

КОМЕНТАРІ • 1

  • @fajraouihedi5895
    @fajraouihedi5895 8 місяців тому

    Thank you for the excellent presentation. Unfortunately some slides are blurry